Analysts are bullish on Adani Enterprises, HAL, and Trent, citing growth drivers like new energy and engine co-production. Aurobindo Pharma’s biologics expansion shows promise but financial gains are distant. Aditya Birla Capital’s housing finance arm impresses with strong loan growth and improved asset quality, despite minor revenue misses. Analysts are bullish on Adani Enterprises, HAL, and Trent, citing growth drivers like new energy and engine co-production. Aurobindo Pharma’s biologics expansion shows promise but financial gains are distant. Aditya Birla Capital’s housing finance arm impresses with strong loan growth and improved asset quality, despite minor revenue misses.
Trending
- CSK, RCB records broken! Punjab Kings become first team in IPL to …
- Top shares to buy: Stock recommendations for today – check list
- Women’s Quota Act of 2023 comes into force
- Oil prices today: Crude falls in early trade on hopes of easing Middle East conflict
- ‘Targeting commercial shipping unacceptable’: India urges safe navigation through Hormuz at UN
- Nitish Kumar Reddy Interview: ‘I have overdone things… now I realise that’
- ‘Broke down in tears’: Artemis II crew recall ‘otherworldly’ experience of their trip to the Moon
- Just weeks before big Siri launch, Apple may send dozens of engineers to bootcamp